Details
Product Name in the RMS: Asimutin
MR Number: EE/H/0313/002
Date of outcome: 14.03.2013
Type of application | |
---|---|
Level 1: Level 2: Level 3: Level 4: Level 5: |
Abridged Additional Strength/Form Generic Chemical Substance Prescription Only |
Active Substances |
azathioprine 50 mg |
Form | Film coated tablet |
MA Holder in the RMS |
PharmaSwiss Ceska republika s.r.o Jankovcova 1569/2c 170 00 Praha 7 Czech Republic |
RMS | Estonia |
Date of last change | 30.12.2020 |
ATC-Code |
L04AX01 Azathioprine |
CMS Country | Domestic Product Name |
---|---|
Czech Republic | Atioprin 50 mg potahované tablety |
Latvia | Atsimutin 50 mg apvalkotās tabletes |
Lithuania | Atsimutin 50 mg plėvele dengtos tabletės |
Slovak Republic |
Documents | |
---|---|
FinalSPC: | EE_H_0313_002_FinalSPC_1of4.pdf (17.07.2017) |
FinalSPC: | EE_H_0313_002_FinalSPC_2of4.pdf (17.07.2017) |
FinalSPC: | EE_H_0313_002_FinalSPC_3of4.pdf (17.07.2017) |
FinalSPC: | EE_H_0313_002_FinalSPC_4of4.pdf (17.07.2017) |
FinalPL: | EE_H_0313_002_FinalPL_1of4.pdf (17.07.2017) |
FinalPL: | EE_H_0313_002_FinalPL_2of4.pdf (17.07.2017) |
FinalPL: | EE_H_0313_002_FinalPL_3of4.pdf (17.07.2017) |
FinalPL: | EE_H_0313_002_FinalPL_4of4.pdf (17.07.2017) |
Finalised Product Information: | EE_H_0313_002_FinalPI_1of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_2of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_3of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_4of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_5of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_6of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_7of8.pdf (09.11.2018) |
Finalised Product Information: | EE_H_0313_002_FinalPI_8of8.pdf (09.11.2018) |